logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
L

Lucas Moreno

chaim sheba medical center
H指数:31
被引数:2,838

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Survival Outcomes with IL-2-Free Dinutuximab Beta Treatment Strategies With or Without 13-cis-Retinoic Acid in Relapsed or Refractory Neuroblastoma: An Exploratory Unanchored, Population-Adjusted Comparison of Two Prospective Cohorts

无IL-2的dinutuximab beta治疗策略（联合或不联合13-顺式维甲酸）在复发或难治性神经母细胞瘤中的生存结局：一项探索性无锚定、人群调整的两前瞻性队列比较

Biomedicines
IF3.9
2026-09-290
OA
Holger N. Lode; Przemysław Holko; Aleksandra Wieczorek; Katarzyna Śladowska; Nikolai Siebert; Dominique Valteau-Couanet; Alberto Garaventa; Adela Cañete; John Anderson; Isaac Yaniv; Shifra Ash; Lucas Moreno; Juliet Gray; Roberto Luksch; Genevieve Laureys; Cormac Owens; Carla Manzitti; Sascha Troschke-Meurer; Paweł Kawalec; Ruth L. Ladenstein
Development of an age specific EORTC questionnaire to assess the health-related quality of life (HRQOL) of children with cancer aged 8-14 years-a mixed-methods content elicitation phase I & II EORTC QLG study

针对8-14岁癌症患儿的年龄特异性EORTC问卷的开发，用于评估其健康相关生活质量（HRQOL）——一项混合方法的内容引出阶段I & II EORTC QLG研究

European Journal of Cancer
IF7.1
2026-09-010
OAAI
Vetrano, Chiara; Balcerek, Magdalena; Rothmund-Grenier, Maria; Sodergren, Samantha; Rohde, Gudrun; Crazzolara, Roman; Meryk, Andreas; de Rojas, Teresa; Al Omari, Amal; Abaza, Haneen; Rubio-San-Simon, Alba; Moreno, Lucas; Formenti, Sara; Bidstrup, Pernille Envold; Oren, Liat; Yarom, Noam; Kuhn-Wolff, Elisabeth; Fischmeister, Gustav; Harvell, Chelsea; Butler, Lauren; Bailey, Shivani; Smith, Honor; Thomas, Sophie; Darlington, Anne-Sophie; Riedl, David
Eligibility criteria in pediatric oncology Phase I and II clinical trials: Analysis and recommendations for standardization from the Innovative Therapies for Children and Adolescents with Cancer (ITCC) Consortium

儿科肿瘤学I期和II期临床试验的入选标准：来自癌症创新疗法儿童与青少年联盟(ITCC)关于标准化的分析和建议

European Journal of Cancer
IF7.1
2026-05-250
PRE
Uri Ilan; Alba Rubio-San-Simón; Natasha van Eijkelenburg; Cormac Owens; Aviva Kraus; Lucas Moreno; Fernando Carceller; Carole Lecinse; Leona Knox; Nicole Scobie; Birgit Geoerger; C. Michel Zwaan; Pamela Kearns; Francisco Bautista
Paediatric Strategy Forum for Medicinal Product Development of Agents Targeting GD2 Ganglioside in Children and Adolescents with Cancer

针对儿童及青少年癌症患者GD2神经节苷脂靶向药物制剂开发儿科策略论坛

European Journal of Cancer
IF7.1
2025-11-050
OAAI
Steven G. DuBois; Lucas Moreno; Rochelle Bagatell; Nai-Kong Cheung; Juliet C. Gray; Franco Locatelli; C. Patrick Reynolds; Claudia Rossig; Paul M. Sondel; Nicole Drezner; Olga Kholmanshikh; Nicholas Bird; Lorna Day; Donna Ludwinski; Nicole Scobie; Vanessa Pons Sanz; Simon Ball; Bonnie Hammer; Ignacio Alvarez Rojo; Danelle Meager; Joen Sveistrup; Pablo Berlanga; Michela Casanova; Julia Glade-Bender; Margaret Macy; Daniel A. Morgenstern; Cormac Owens; Brenda J. Weigel; Alberto Pappo; Karsten Nysom; John Anderson; Franca Ligas; Giovanni Lesa; Martha Donoghue; Dominik Karres; Gilles Vassal
Recommended phase 2 dose for abemaciclib in combination with irinotecan and temozolomide in pediatric and young adult patients with relapsed/ refractory solid tumors: Results from JPCS study (Part A)

推荐阿贝西利（abemaciclib）联合伊立替康（irinotecan）和替莫唑胺（temozolomide）在复发/难治性实体瘤的儿童和年轻成年患者中的Ⅱ期剂量：JPCS研究（部分A）的结果

EJC Paediatric Oncology
IF0
2025-11-010
OAAI
Ribelles, Antonio Juan; Moreno, Lucas; Ogawa, Chitose; Thorwarth, Anne; Ruggiero, Antonio; Pitou, Celine; Zhou, Yanhong; Hardebeck, Molly C.; Knoderer, Holly; Lassaletta, Alvaro
Southern European Prospective Investigation Into Childhood Cancer and Nutrition (EPICkids): Study design and protocol

南欧前瞻性儿童癌症与营养研究(EPICkids)：研究设计与方案

PLOS ONE
IF2.6
2025-09-050
OAAI
Perganti, Foteini; Huybrechts, Inge; Balduzzi, Adriana Cristina; Barr, Ronald; Biondi, Andrea; Blade, Aina Llenas; Munoz Bravo, Evangelina; Damasco, Erika; Katsagoni, Christina N.; Kattamis, Antonis; Lassaletta, Alvaro; Llopis Lera, Marta; Llort, Anna; Blanco Lopez, Jessica; Perez Martinez, Antonio; Massimino, Maura; Morales La Madrid, Andres; Moreno, Lucas; Munoz Alonso, Ana; Nicolas, Genevieve; Preziati, Giorgia; Rizzari, Sofia; Della Valle, Serena; Marquez Vega, Catalina; Walters, Michelle; Kozlakidis, Zisis; Ladas, Elena J.
Implementation of the precision oncology program in catalonia’s public health system: results, lessons learned, and future prospects

在加泰罗尼亚公共健康体系中实施精准肿瘤学计划：结果、经验教训及未来展望

clinical translational oncology
IF0
2025-09-030
OAAI
Pilar Mur; Anna Pozuelo; Josep Tabernero; Joan Albanell; Beatriz Bellosillo; Francesc Bosch; Javier Briones; Joan Brunet; Dolors Colomer; Montserrat Domènech; Joan Manel Fontanet; Xavier Matias-Guiu; Ramon Salazar; Rosa Maria Vivanco-Hidalgo; Meritxell Mollà; Lucas Moreno; Aleix Prat; Josep Maria Ribera; Ramón Clèries; Alex Guarga; Josep A. Espinàs; Josep Maria Borras
International neuroblastoma risk group consortium: a model of networking for rare cancers
JNCI: Journal of the National Cancer Institute
IF0
2025-08-250
OAAI
Susan L Cohn, MD; Wendy B London, PhD; Gudrun Schleiermacher, MD, PhD; Lucas Moreno, MD, PhD; Inge M Ambros, PhD; Peter F Ambros, PhD; Rochelle Bagatell, MD; Maja Beck Popovic, MD; Klaus Hermann Beiske, MD, PhD; Frank Berthold, MD; Suzi Birz, MScMI; Hervé J Brisse, MD; Garrett M Brodeur, MD; Penelope R Brock, MD; Susan Burchill, PhD; Angelika Eggert, MD; Sara M Federico, MD; Matthias Fischer, PhD; Brian T Furner, MS; Barbara Hero, MD; David Machin, PhD; Takehiko Kamijo, MD; Katherine K Matthay, MD; Akira Nakagawara, MD, PhD; Arlene Naranjo, PhD; Ulrike Pötschger, PhD; Dominique Valteau-Couanet, MD; Michael T Watkins, PhD; Meredith S Irwin, MD; Samuel L Volchenboum, MD, PhD; Julie R Park, MD; Andrew D J Pearson, MD; null
Management and outcome of children with high-risk neuroblastoma: insights from the Spanish Society of Pediatric Hematology and Oncology (SEHOP) neuroblastoma group on refractory and relapse/progressive disease (Feb, 10.1007/s12094-025-03853-w, 2025)

高风险神经母细胞瘤患儿的诊疗与管理：来自西班牙儿科血液学与肿瘤学会（SEHOP）神经母细胞瘤组关于难治性及复发/进展性疾病的研究见解（2025年2月，10.1007/s12094-025-03853-w）

CLINICAL & TRANSLATIONAL ONCOLOGY
IF2.5
2025-04-090
OA
de las Heras, Blanca Martinez; Rubio-Aparicio, Pedro M.; Rubio-San-Simon, Alba; Moreno, Lucas; Mazorra, Paula; Almaraz, Ricardo Lopez; Lopez, Mercedes Llempen; Guill, Julia Balaguer; Segura, Vanessa; Bermudez, Mar; Jimenez, Irene; Ramal, Desiree; Canete, Adela
A comprehensive clinico-pathological review of a series of pediatric, adolescents and young adults with high-grade osteosarcoma: from clinics to biomarker discovery

对一组儿科、青少年及年轻成年高分级骨肉瘤患者的全面临床病理学回顾：从临床到生物标志物发现

CLINICAL & TRANSLATIONAL ONCOLOGY
IF2.5
2025-04-080
PRE
Buendia-Lopez, Susana; Rubio-San-Simon, Alba; Wu, Jen-Hao; Azorin-Cuadrillero, Daniel; Sanz-Miguel, Ana; Lassaletta, Alvaro; Sirvent-Cerda, Sara Inmaculada; Rey-Portela, Laura; Abril, Juan Carlos; Moreno, Lucas; Madero-Lopez, Luis; Garcia-Castro, Javier; Bautista, Francisco
Clinical and psychological implications of secondary and incidental findings in cancer susceptibility genes after exome sequencing in patients with rare disorders

罕见疾病患者外显子组测序后癌症易感基因的次要和偶然发现的临床和心理意义

JOURNAL OF MEDICAL GENETICS
IF3.7
2022-11-296
PRE
Carrasco, Estela; Lopez-Fernandez, Adria; Codina-Sola, Marta; Valenzuela, Irene; Cueto-Gonzalez, Am; Villacampa, Guillermo; Navarro, Victor; Torres-Esquius, Sara; Palau, Dolors; Cruellas, Mara; Torres, Maite; Perez-Duenas, Belen; Abuli, Anna; Diez, Orland; Sabado-Alvarez, Constantino; Garcia-Arumi, Elena; Tizzano, Eduardo F.; Moreno, Lucas; Balmana, Judith
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastoma
CELLULAR AND MOLECULAR LIFE SCIENCES
IF6.2
2022-10-117
OAAI
Navarro, Natalia; Molist, Carla; Sansa-Girona, Julia; Zarzosa, Patricia; Gallo-Oller, Gabriel; Pons, Guillem; Magdaleno, Ainara; Guillen, Gabriela; Hladun, Raquel; Garrido, Marta; Segura, Miguel F.; Hontecillas-Prieto, Lourdes; de Alava, Enrique; Ponsati, Berta; Fernandez-Carneado, Jimena; Almazan-Moga, Ana; Valles-Miret, Mariona; Farrera-Sinfreu, Josep; Sanchez de Toledo, Josep; Moreno, Lucas; Gallego, Soledad; Roma, Josep
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting

难治性，复发性或进行性神经母细胞瘤的早期临床试验资格和反应评估标准: 美国国家癌症研究所临床试验计划会议的共识声明

CANCER
IF5.1
2022-09-135
OAAI
Park, Julie R.; Villablanca, Judith G.; Hero, Barbara; Kushner, Brian H.; Wheatley, Keith; Beiske, Klaus H.; Ladenstein, Ruth L.; Baruchel, Sylvain; Macy, Margaret E.; Moreno, Lucas; Seibel, Nita L.; Pearson, Andrew D.; Matthay, Katherine K.; Valteau-Couanet, Dominique
Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program

BAF染色质重塑蛋白的结构破坏通过恢复侵袭性表观基因组程序损害神经母细胞瘤转移

MOLECULAR CANCER
IF33.9
2022-09-038
OAAI
Jimenez, Carlos; Antonelli, Roberta; Nadal-Ribelles, Mariona; Devis-Jauregui, Laura; Latorre, Pablo; Sole, Carme; Masanas, Marc; Molero-Valenzuela, Adria; Soriano, Aroa; de Toledo, Josep Sanchez; Llobet-Navas, David; Roma, Josep; Posas, Francesc; de Nadal, Eulalia; Gallego, Soledad; Moreno, Lucas; Segura, Miguel F.

研究方向

暂未获取到该数据
A
Andrew D.J. Pearson
H 指数:70论文数:358被引数:1.8万
L
Lynley V. Marshall
H 指数:34论文数:296被引数:4,920
S
Soledad Gallego
H 指数:35论文数:222被引数:4,462
M
Miguel F. Segura
H 指数:35论文数:152被引数:5,135
G
Gilles Vassal
H 指数:72论文数:705被引数:1.9万
F
Francisco Bautista
H 指数:22论文数:184被引数:2,063
J
Josep Roma
H 指数:23论文数:101被引数:1,352
B
Birgit Geoerger
H 指数:57论文数:590被引数:1.3万
F
Fernando Carceller
H 指数:34论文数:331被引数:3,857
M
Michela Casanova
H 指数:64论文数:527被引数:1.4万